194 related articles for article (PubMed ID: 17175127)
1. Palliation for suspected unresectable hilar cholangiocarcinoma.
Connor S; Barron E; Redhead DN; Ireland H; Madhavan KK; Parks RW; Garden OJ
Eur J Surg Oncol; 2007 Apr; 33(3):341-5. PubMed ID: 17175127
[TBL] [Abstract][Full Text] [Related]
2. Unresectable cholangiocarcinoma: comparison of survival in biliary stenting alone versus stenting with photodynamic therapy.
Kahaleh M; Mishra R; Shami VM; Northup PG; Berg CL; Bashlor P; Jones P; Ellen K; Weiss GR; Brenin CM; Kurth BE; Rich TA; Adams RB; Yeaton P
Clin Gastroenterol Hepatol; 2008 Mar; 6(3):290-7. PubMed ID: 18255347
[TBL] [Abstract][Full Text] [Related]
3. Selective intrahepatic duct cannulation by using a triple-lumen catheter for endoscopic bilateral stenting in hilar cholangiocarcinoma.
Kim JY; Kang DH; Choi CW; Kim HW; Park SB; Kim DU
Gastrointest Endosc; 2010 Jul; 72(1):192-8. PubMed ID: 20546732
[TBL] [Abstract][Full Text] [Related]
4. Palliative treatment with self-expandable metallic stents in patients with advanced type III or IV hilar cholangiocarcinoma: a percutaneous versus endoscopic approach.
Paik WH; Park YS; Hwang JH; Lee SH; Yoon CJ; Kang SG; Lee JK; Ryu JK; Kim YT; Yoon YB
Gastrointest Endosc; 2009 Jan; 69(1):55-62. PubMed ID: 18657806
[TBL] [Abstract][Full Text] [Related]
5. Biliary drainage, photodynamic therapy and chemotherapy for unresectable cholangiocarcinoma with jaundice.
Fuks D; Bartoli E; Delcenserie R; Yzet T; Celice P; Sabbagh C; Chatelain D; Joly JP; Cheron N; Dupas JL; Regimbeau JM
J Gastroenterol Hepatol; 2009 Nov; 24(11):1745-52. PubMed ID: 19780885
[TBL] [Abstract][Full Text] [Related]
6. Endoscopic and surgical therapy for intrahepatic cholangiocarcinoma in the united states: a population-based study.
Shaib YH; Davila JA; Henderson L; McGlynn KA; El-Serag HB
J Clin Gastroenterol; 2007; 41(10):911-7. PubMed ID: 18090160
[TBL] [Abstract][Full Text] [Related]
7. Unresectable hilar cholangiocarcinoma: multimodality approach with percutaneous treatment associated with radiotherapy and chemotherapy.
Golfieri R; Giampalma E; Renzulli M; Galuppi A; Vicenzi L; Galaverni MC; Cappelli A
In Vivo; 2006; 20(6A):757-60. PubMed ID: 17203762
[TBL] [Abstract][Full Text] [Related]
8. Palliative surgical bypass versus percutaneous transhepatic biliary drainage on unresectable hilar cholangiocarcinoma.
Wongkonkitsin N; Phugkhem A; Jenwitheesuk K; Saeseow OT; Bhudhisawasdi V
J Med Assoc Thai; 2006 Nov; 89(11):1890-5. PubMed ID: 17205870
[TBL] [Abstract][Full Text] [Related]
9. Diagnosis and surgical treatment of hepatic hilar cholangiocarcinoma.
Yang WL; Zhang XC; Zhang DW; Tong BF
Hepatobiliary Pancreat Dis Int; 2007 Dec; 6(6):631-5. PubMed ID: 18086631
[TBL] [Abstract][Full Text] [Related]
10. Combined biliary and gastric bypass procedures as effective palliation for unresectable malignant disease.
Mann CD; Thomasset SC; Johnson NA; Garcea G; Neal CP; Dennison AR; Berry DP
ANZ J Surg; 2009 Jun; 79(6):471-5. PubMed ID: 19566872
[TBL] [Abstract][Full Text] [Related]
11. Impact of intraoperative radiotherapy (IORT) on survival of patients with unresectable hilar cholangiocarcinoma.
Kaiser GM; Frühauf NR; Lang H; Sauerwein W; Sotiropoulos GC; Zöpf T; Grabellus F; Wittig A; Oldhafer KJ; Malagó M; Broelsch CE
Hepatogastroenterology; 2008; 55(88):1951-4. PubMed ID: 19260456
[TBL] [Abstract][Full Text] [Related]
12. Bile duct carcinoma: trends in treatment in the nineties.
Reed DN; Vitale GC; Martin R; Bas H; Wieman TJ; Larson GM; Edwards M; McMasters K
Am Surg; 2000 Aug; 66(8):711-4; discussion 714-5. PubMed ID: 10966023
[TBL] [Abstract][Full Text] [Related]
13. Palliative surgery for hilar cholangiocarcinoma.
Li HM; Dou KF; Sun K; Gao ZQ; Li KZ; Fu YC
Hepatobiliary Pancreat Dis Int; 2003 Feb; 2(1):110-3. PubMed ID: 14607660
[TBL] [Abstract][Full Text] [Related]
14. Palliation of unresectable periampullary neoplasms. "surgical" versus "non-surgical" approach.
Nuzzo G; Clemente G; Cadeddu F; Giovannini I
Hepatogastroenterology; 2004; 51(59):1282-5. PubMed ID: 15362733
[TBL] [Abstract][Full Text] [Related]
15. [Non-resectable neoplasms of the biliary duct: palliative surgery vs non-surgical management].
Tocchi A; Costa G; Lepre L; Liotta G; Mazzoni G; Sita A
G Chir; 1996; 17(8-9):408-12. PubMed ID: 9004835
[TBL] [Abstract][Full Text] [Related]
16. Changing trends in surgical outcomes after major hepatobiliary resection for hilar cholangiocarcinoma: a single-center experience over 25 years.
Sano T; Shimada K; Sakamoto Y; Esaki M; Kosuge T
J Hepatobiliary Pancreat Surg; 2007; 14(5):455-62. PubMed ID: 17909713
[TBL] [Abstract][Full Text] [Related]
17. Endoscopic irradiation and parallel arrangement of Wallstents for hilar cholangiocarcinoma.
Kubota Y; Takaoka M; Kin H; Ogura M; Yamamoto S; Tsuji K; Yanagitani K; Inoue K
Hepatogastroenterology; 1998; 45(20):415-9. PubMed ID: 9638416
[TBL] [Abstract][Full Text] [Related]
18. ERCP-directed radiofrequency ablation and photodynamic therapy are associated with comparable survival in the treatment of unresectable cholangiocarcinoma.
Strand DS; Cosgrove ND; Patrie JT; Cox DG; Bauer TW; Adams RB; Mann JA; Sauer BG; Shami VM; Wang AY
Gastrointest Endosc; 2014 Nov; 80(5):794-804. PubMed ID: 24836747
[TBL] [Abstract][Full Text] [Related]
19. Endoscopic management of cholangiocarcinoma.
Abu-Hamda EM; Baron TH
Semin Liver Dis; 2004 May; 24(2):165-75. PubMed ID: 15192789
[TBL] [Abstract][Full Text] [Related]
20. Current management of hilar cholangiocarcinoma.
Stain SC; Baer HU; Dennison AR; Blumgart LH
Surg Gynecol Obstet; 1992 Dec; 175(6):579-88. PubMed ID: 1280374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
